Synthesis and biological evaluation of 3-alkoxy analogues of flavone-8-acetic acid

Journal of Medicinal Chemistry

Volumn 46, Issue 17, 2003, Pages 3662-3669

  Gobbi, Silvia ^a   Rampa, Angela ^a   Bisi, Alessandra ^a   Belluti, Federica ^a   Piazzi, Lorna ^a   Valenti, Piero ^a   Caputo, Anna ^b   Zampiron, Antonella ^b   Carrara, Maria ^b  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b UNIVERSITY OF PADOVA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

5,6 DIMETHYLXANTHENONE 4 ACETIC ACID; BENZENE DERIVATIVE; FLAVONE DERIVATIVE; MITOFLAXONE; XANTHONE 4 ACETIC ACID;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; DRUG SYNTHESIS; HUMAN; HUMAN CELL; MACROPHAGE; MONOCYTE; MOUSE; NONHUMAN; TUMOR CELL LINE;

ANIMALS; DRUG SCREENING ASSAYS, ANTITUMOR; FLAVONOIDS; HUMANS; LEUKOCYTES, MONONUCLEAR; MACROPHAGES; MAGNETIC RESONANCE SPECTROSCOPY; MASS SPECTROMETRY; MICE; MONOCYTES; STRUCTURE-ACTIVITY RELATIONSHIP; TUMOR CELLS, CULTURED; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0042231993     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm030771o     Document Type: Article

References (36)

1. Atassi, G.; Briet, P.; Berthelon, J. J.; Collonges, F. Synthesis and antitumor activity of some 8-substituted-4-oxo-4H-1-benzopyrans. Eur. J. Med. Chem. 1985, 20, 393-402.
2. Plowman, J.; Narayanan, V. L.; Dykes, D.; Szarvasi, E.; Briet, P.; Yader, O. C.; Paull, K. D. Flavone acetic acid: a novel agent with preclinical anti-tumor activity against colon adenocarcinoma 38 in mice. Cancer Treat. Rep. 1986, 70, 631-635.
3. Ching, L. M.; Baguley, B. C. Enhancement of in vitro cytotoxicity of mouse peritoneal exudate cells by flavone acetic acid. Eur. J. Cancer Clin. Oncol. 1988, 24, 1521-1525.
4. Ching, L. M.; Baguley, B. C. Induction of natural killer cell activity by the antitumor compound flavone acetic acid (NSC 347512). Eur. J. Cancer Clin. Oncol. 1987, 23, 1047-1050.
5. Smith, G. P.; Calveley, S. B.; Smith, M. J.; Baguley, B. C. Flavone acetic acid (NSC 347512) induces haemorrhagic necrosis of mouse colon 26 and 38 tumors. Eur. J. Cancer Clin. Oncol. 1987, 23, 1209-1211.
6. Bibby, M. C.; Double, J. A.; Loadman, P. M.; Duke, C. V. Reduction of tumor blood flow by flavone acetic acid: a possible componenet of therapy. J. Natl. Cancer Inst. 1989, 81, 216-220.
7. Baguley, B. C.; Calveley, S. B.; Crowe, K. K.; Fray, L. M.; O'Rourke, S. A.; Smith, G. P. Comparison of the effects of flavone acetic acid, fostriecin, homoharringtonine and tumor necrosis factor alpha on colon 38 tumors in mice. Eur. J. Cancer Clin. Oncol. 1989, 25, 263-269.
8. Mace, K. F.; Hornung, R. L.; Wiltrout, R. H.; Young, H. A. Correlation between in vivo induction of cytokine gene expression by flavone acetic acid and strict dose dependency and therapeutic efficacy against murine renal cancer. Cancer Res. 1990, 50, 1742-1747.
9. Bibby, M. C.; Double, J. A. Flavone acetic acid-from laboratory to clinic and back. Anti-Cancer Drugs 1993, 4, 3-17.
10. Rewcastle, G. W.; Atwell, G. J.; Baguley, B. C.; Calveley, S. B.; Denny, W. A. Potential antitumor agents. 58. Synthesis and structure-activity relationships of substituted xanthenone-4-acetic acids active against the colon 38 tumor in vivo. J. Med. Chem. 1989, 32, 793-799.
11. Baguley, B. C.; Ching, L. M. Immunomodulatory actions of xanthenone anticancer agents. BioDrugs 1997, 8, 119-127.
12. Jameson, M. B.; Thompson, P. I.; Baguley, B. C.; Evans, B. D.; Harvey, V. J.; Porter, D. J.; McCrystal, M. R.; Kestell, P. Phase I pharmacokinetic and pharmacodynamic study of 5,6-dimethylxanthenone-4-acetic acid (DMXAA), a novel antivascular agent. Proc. Am. Soc. Clin. Oncol. 2000, 19, 182a.
13. Candeias, L. P.; Everett, S. A.; Wardman, P. Free radical intermediates in the oxidation of flavone-8-acetic acid: possible involvement in its antitumor activity. Free Radical Biol. Med. 1993, 15, 385-394.
14. Everett, S. A.; Candelas, L. P.; Denny, W. A.; Wardman, P. Decarboxylation of the antitumour drugs flavone-8-acetic acid and xanthenone-4-acetic acid by nitrogen dioxide. Anti-Cancer Drug Des. 1994, 9, 68-72.
15. Aitken, R. A.; Bibby, M. C.; Cooper, P. A.; Double, J. A.; Laws, A. L.; Ritchie, R. B.; Wilson, D. W. J. Synthesis and antitumour activity of new derivatives of flavone-8-acetic acid (FAA). Part 4: variation of the basic structure. Arch. Pharm. (Weinheim, Ger.) 2000, 333, 181-188 and references therein.
16. (a) Valenti, P.; Fabbri, G.; Rampa, A.; Bisi, A.; Gobbi, S.; Da Re, P.; Carrara, M.; Sgevano, A.; Cima, L. Synthesis and antitumor activity of some analogues of flavone acetic acid. Anti-Cancer Drug Des. 1996, 11, 243-252.
17. (b) Valenti, P.; Bisi, A.; Rampa, A. Gobbi, S.; Belluti, F.; Da Re P.; Carrara, M.; Cima, L. Synthesis of flavone-2′-carboxylic acid analogues as potential antitumor agents. Anti-Cancer Drug Des. 1998, 13, 881-892.
18. (c) Valenti, P.; Bisi, A.; Rampa, A.; Belluti, F.; Gobbi, S.; Zampiron, A.; Carrara, M. Synthesis and biological activity of some rigid analogues of flavone-8-acetic acid. Bioorg. Med. Chem. 2000, 8, 239-246.
19. Gobbi, S.; Rampa, A.; Bisi, A.; Belluti, F.; Valenti, P.; Caputo, A.; Zampiron, A.; Carrara, M. Synthesis and antitumor activity of some rigid derivatives of xanthen-9-one-4-acetic acid. J. Med. Chem. 2002, 45 (22), 4931-4939.
20. Enebaeck, C.; Gripenberg, J. Confirmation of the structure of 2-benzyl-2-hydroxycoumaran-3-ones. Acta Chem. Scand. 1957, 11, 866-872.
21. Marverti, G.; Andrews, P. A. Stimulation of cis-diamminedichloroplatinum(II) accumulation by modulation of passive permeability with genistein: an altered response in accumulation-defective resistant cells. Clin. Cancer Res. 1996, 2, 991-999.
22. (a) Zinkewich-Peotti, K.; Andrews, P. A. Loss of cis-diamminedichloroplatinum(II) resistance in human ovarian carcinoma cells selected for rhodamine 123 resistance. Cancer Res. 1992, 52, 1902-1906.
23. (b) Andrews, P. A.; Albright, K. D. Mithocondrial defects in cis-diamminedichloroplatinum(II)-resistant human ovarian carcinoma cells. Cancer Res. 1992, 52, 1895-1901.
24. Philpott, M.; Baguley, B. C.; Ching, L. M. Induction of tumour necrosis factor-alpha by single and repeated doses of the antitumour agent 5,6-dimethylxanthenone-4-acetic acid. Cancer Chemother. Pharmacol. 1995, 36, 143-148.
25. Philpott, M.; Joseph, W. R.; Crosier, K. E.; Baguley, B. C.; Ching, L. M. Production of tumour necrosis factor-alpha by cultured human peripheral blood leucocytes in response to the anti-tumour agent 5,6-dimethylxanthenone-4-acetic acid (NSC 640488). Br. J. Cancer 1997, 76, 1586-1591.
26. Carswell, E. A.; Old, L. J.; Kassel, R. L.; Green, S.; Fiore, N.; Williamson, B. An endotoxin-induced serum factor that causes necrosis of tumors. Proc. Natl. Acad. Sci. U.S.A. 1975, 72, 3666-3670.
27. Aitken, A. R.; Bibby, M. C.; Double, J. A.; Laws, A. L.; Ritchie, R. B.; Wilson, D. W. J. Synthesis and antitumour activity of new derivatives of flavone-8-acetic acid (FAA). Part 2: ring-substituted derivatives. Arch. Pharm. (Weinheim, Ger.) 1997, 330, 215-224.
28. Philpott, M.; Ching, L. M.; Baguley, B. C. The antitumour agent 5,6-dimethylxanthenone-4-acetic acid acts in vitro on human mononuclear cells as a co-stimulator with other inducers of tumour necrosis factor. Eur. J. Cancer 2001, 37, 1930-1937.
29. Wright, S. D.; Ramos, R. A.; Tobias, P. S.; Ulevitch, R. J.; Mathison, J. C. CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science 1990, 249, 1431-1433.
30. Yang, R. B.; Mark, M. R.; Gray, A.; Huang, A.; Xie, M. H.; Goddard, A.; Wood, W. I.; Gurney, A. L.; Godowski, P. J. Toll-like receptor-2 mediates lipopolysaccharide-induced cellular signalling. Nature 1998, 395, 284-288.
31. Zhang, F. X.; Kirschning, C. J.; Mancinelli, R.; Xu, X. P.; Jin, Y.; Faure, E.; Mantovani, A.; Rothe, M.; Muzio, M.; Arditi, M. Bacterial lipopolysaccharide activates nuclear factor-kappa R through interleukin-1 signalling mediators in cultured human dermal endothelial cells and mononuclear phagocytes. J. Biol. Chem. 1999, 274, 7611-7614.
32. Mosmann, T. J. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assay. Immunol. Methods 1983, 65, 55.
33. Ching, L. M.; Finlay, G. J.; Joseph, W. R.; Baguley, B. C. In vitro methods for screening agents with an indirect mechanism of antitumour activity: xanthenone analogues of flavone acetic acid. Eur. J. Cancer 1991, 27, 1684-1689.
34. Patel, S.; Parkin, S. M.; Bibby, M. C. The effect of 5,6-dimethylxanthone-4-acetic acid on tumour necrosis factor production by human immune cells. Anticancer Res. 1997, 17, 141-150.
35. Garbin, F.; Eckert, K.; Immenschuh, P.; Kreuser, E. D.; Maurer, H. R. Prothymosin α1 effects, in vitro, on the antitumor activity and cytokine production of blood monocytes from colorectal tumor patients. Int. J. Immunopharmacol. 1997, 19, 323-332.
36. Tallarida, R. J., Murray, R. B., Eds. Manual of Pharmacological Calculations with Computer Programs, 2nd ed.; Springer-Verlag: New York, 1987; p 153.